168 related articles for article (PubMed ID: 27466499)
1. Expression of Endoglin and Vascular Endothelial Growth Factor as Prognostic Markers in Experimental Colorectal Cancer.
Ilhan N; Gungor H; Gul HF; Eroksuz H
Anticancer Res; 2016 Aug; 36(8):3953-9. PubMed ID: 27466499
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of cyclooxygenase-2 inhibitors and evaluation of angiogenesis in the model of experimental colorectal cancer.
Gungor H; Ilhan N; Eroksuz H
Biomed Pharmacother; 2018 Jun; 102():221-229. PubMed ID: 29562216
[TBL] [Abstract][Full Text] [Related]
3. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer.
Saad RS; Liu YL; Nathan G; Celebrezze J; Medich D; Silverman JF
Mod Pathol; 2004 Feb; 17(2):197-203. PubMed ID: 14657950
[TBL] [Abstract][Full Text] [Related]
4. Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Sluiter NR; de Cuba EM; Kwakman R; Meijerink WJ; Delis-van Diemen PM; Coupé VM; Beliën JA; Meijer GA; de Hingh IH; te Velde EA
Clin Exp Metastasis; 2016 Apr; 33(4):297-307. PubMed ID: 26873137
[TBL] [Abstract][Full Text] [Related]
5. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
[TBL] [Abstract][Full Text] [Related]
6. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma.
Saad RS; El-Gohary Y; Memari E; Liu YL; Silverman JF
Hum Pathol; 2005 Sep; 36(9):955-61. PubMed ID: 16153457
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cells.
Valverde A; Peñarando J; Cañas A; López-Sánchez LM; Conde F; Hernández V; Peralbo E; López-Pedrera C; de la Haba-Rodríguez J; Aranda E; Rodríguez-Ariza A
PLoS One; 2015; 10(6):e0131363. PubMed ID: 26107817
[TBL] [Abstract][Full Text] [Related]
9. Diclofenac, a selective COX-2 inhibitor, inhibits DMH-induced colon tumorigenesis through suppression of MCP-1, MIP-1α and VEGF.
Kaur J; Sanyal SN
Mol Carcinog; 2011 Sep; 50(9):707-18. PubMed ID: 21268133
[TBL] [Abstract][Full Text] [Related]
10. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
11. Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer.
Nogués A; Gallardo-Vara E; Zafra MP; Mate P; Marijuan JL; Alonso A; Botella LM; Prieto MI
World J Surg Oncol; 2020 May; 18(1):99. PubMed ID: 32434528
[TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer.
Nikiteas NI; Tzanakis N; Theodoropoulos G; Atsaves V; Christoni Z; Karakitsos P; Lazaris AC; Papachristodoulou A; Klonaris C; Gazouli M
Gastric Cancer; 2007; 10(1):12-7. PubMed ID: 17334712
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.
Kim JY; Bae BN; Kwon JE; Kim HJ; Park K
APMIS; 2011 Jul; 119(7):449-59. PubMed ID: 21635552
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of Colon Cancer through Inhibition of Angiogenesis and Induction of Apoptosis by Nonsteroidal Anti-Inflammatory Drugs.
Ghanghas P; Jain S; Rana C; Sanyal SN
J Environ Pathol Toxicol Oncol; 2016; 35(3):273-289. PubMed ID: 27910782
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin and vascular endothelial growth factor expression in colorectal disease models.
Liu WX; Gu SZ; Zhang S; Ren Y; Sang LX; Dai C
World J Gastroenterol; 2015 Mar; 21(9):2645-50. PubMed ID: 25759532
[TBL] [Abstract][Full Text] [Related]
17. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712
[TBL] [Abstract][Full Text] [Related]
18. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma.
El-Gohary YM; Silverman JF; Olson PR; Liu YL; Cohen JK; Miller R; Saad RS
Am J Clin Pathol; 2007 Apr; 127(4):572-9. PubMed ID: 17369132
[TBL] [Abstract][Full Text] [Related]
19. Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis.
Cressey R; Wattananupong O; Lertprasertsuke N; Vinitketkumnuen U
BMC Cancer; 2005 Oct; 5():128. PubMed ID: 16202150
[TBL] [Abstract][Full Text] [Related]
20. mRNA expression of the angiogenesis markers VEGF and CD105 (endoglin) in human breast cancer.
Gómez-Esquer F; Agudo D; Martínez-Arribas F; Nuñez-Villar MJ; Schneider J
Anticancer Res; 2004; 24(3a):1581-5. PubMed ID: 15274325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]